Reported Earlier, lvotech Prices $152M Public Offering And Concurrent Private Placement Of 40.5M Ordinary Shares At $3.75 Per Share To Fund Biosimilar Development

Loading news article.

Reported Earlier, lvotech Prices $152M Public Offering And Concurrent Private Placement Of 40.5M Ordinary Shares At $3.75 Per Share To Fund Biosimilar Development | WAPE

Reported Earlier, lvotech Prices $152M Public Offering And Concurrent Private Placement Of 40.5M Ordinary Shares At $3.75 Per Share To Fund Biosimilar Development

Article summary

Related companies

Comments —